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Ways & MeansApplication of NMR in Structural
Proteomics: Screening for Proteins
Amenable to Structural Analysis
ples is expected to be the rate-determining step in any
structural proteomics project [14, 15].
In a recent investigation of roughly 500 proteins from
the genome of a single organism, Christendat et al. [14,
16] found that only10%–15% of these proteins yielded





samples that were of sufficient quality for structural anal-
ysis by either NMR spectroscopy or X-ray crystallogra-
phy. Clearly, a method to screen for these well-behaved
Summary proteins as well as to optimize the samples of the many
others is urgently needed.
In the time of structural proteomics when protein The unique strength of NMR lies in its capability to
structures are targeted on a genome-wide scale, the semiquantitatively estimate unstructured regions of the
detection of “well-behaved” proteins that would yield polypeptide chain in the otherwise partially folded pro-
good quality NMR spectra or X-ray images is the key tein and to identify proteins that are heterogeneous be-
to high-throughput structure determination. Already, cause of aggregation or other conformational effects.
simple one-dimensional proton NMR spectra provide We will illustrate the various applications of NMR in
enough information for assessing the folding proper- structural proteomics using examples from our own
ties of proteins. Heteronuclear two-dimensional spec- work; this article is not intended to review the literature,
tra are routinely used for screenings that reveal struc- but rather to provide typical examples, of these NMR
tural, as well as binding, properties of proteins. NMR applications.
can thus provide important information for optimizing
conditions for protein constructs that are amenable One-Dimensional NMR
to structural studies. A simple one-dimensional proton experiment, the most
basic spectrum in NMR spectroscopy that can be ac-
quired in a short time (usually not longer than a fewIntroduction
minutes) for samples as dilute as 0.01 mM, already con-
tains a great amount of information. The lower panel ofIt has been widely assumed that nuclear magnetic reso-
Figure 1 shows an example of an unfolded protein withnance spectroscopy will play an important role in struc-
a large and broad signal at approximately 8.3 ppm. Antural proteomics, complementing X-ray crystallography
unfolded protein shows a small dispersion of the amidefor small- and medium-size proteins (below 30 kDa) [1,
backbone chemical shifts [17]. Particularly, the appear-2]. About 17% of the structures deposited in the Protein
ance of intensities at chemical shifts near 8.3 ppm isData Bank, most of which do not have corresponding
an excellent indicator for a disordered protein, as thiscrystal structures, have been solved by NMR spectros-
is a region characteristic of backbone amides in ran-copy [2, 3]. We believe, however, that NMR will remain
dom-coil configuration. On the other hand signal disper-a “poor daughter” of the X-ray method in determining
sion beyond 8.5 ppm (8.5–11 ppm) proves a protein tostructures of proteins. Nevertheless, NMR can deliver
be folded. Because of the different chemical environ-strong results in several areas of structural biochemistry.
ment and, thus, the varying shielding effects, the reso-It is the basis for a wide range of experiments to deter-
nances of the single protons will be distributed over amine structure-function relationships [4], to find binding
wide range of frequencies. A typical intensity pattern ofpartners with their specific binding sites [5], to investi-
a folded protein is shown in the upper panel of Figuregate dynamics of proteins [6], to distinguish multiple
1. Following the same argument, in the aliphatic regionconformations [7], to compare apo and holo forms of
of the spectrum, between 1.0 and 1.0 ppm, a largeproteins and map the binding sites of their cofactors
signal dispersion versus a steep flank of the dominant[8], or to determine pKa values of ionizable groups [9],
peaks at approximately 1 ppm separates a structuredto name just a few. A series of spectra taken under
protein from an unfolded protein (Figure 1, upper anddifferent conditions may be used to monitor aggregation
lower panels, respectively).and formation of amyloid fibrils [10], to determine KD
Close inspection of one-dimensional spectra will alsovalues of binding partners [4], or to track hydrogen ex-
yield quantitative information on the extent of folding inchange with real-time NMR in proteins dissolved in D2O
partially structured proteins or their domains. Figure 2[11]. The ability to detect ligands binding only very
shows two spectra of a 20 kDa protein. In the upperweakly to target molecules has made NMR also increas-
spectrum a mixture of approximately 50%-folded andingly important in drug discovery [12, 13].
50%-unfolded protein can be identified by observingIn this report we focus on the application of NMR
both the signal dispersion and the prominent peak atfor screening for protein samples that are suitable for
8.3 ppm. The lower spectrum shows the same samplestructure elucidation by both NMR spectroscopy and
after removal of the unfolded macromolecules by gelX-ray crystallography. Securing “well-behaved” sam-
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Figure 1. Characterization of Protein Struc-
tures by One-Dimensional NMR Spec-
troscopy
(A) A typical one-dimensional proton NMR
spectrum of a folded protein with signal dis-
persion downfield (left) of 8.5 ppm and upfield
(to the right) of 1 ppm. Spectra show the N-ter-
minal 176-residue domain of the cyclase-
associated protein (CAP) at pH 7.3.
(B) An unfolded protein sample. Strong sig-
nals appear around 8.3 ppm, the region char-
acteristic for amide groups in random-coil
conformation. No signal dispersion is visible
below approximately 8.5 ppm. Also, to the
right of the strong methyl peak at 0.8 ppm,
no further signals show up. The sample is an
unfolded domain of the IGF binding protein
4 (IGFBP-4, residues 147–229).
filtration. The “random-coil peak” disappeared, and the by observing the line width of the signals. Because of
faster relaxation mechanisms, the NMR signal fromsignal pattern is that of a completely structured protein.
While the signal dispersion of the resonances is gener- larger molecules will decay much faster than that from
smaller ones [18]. This, in turn, will produce broaderally connected to folding, aggregation can be detected
Figure 2. The Amide Region of a 20 kDa Protein
The upper trace shows a 1:1 mixture of folded and unfolded proteins; the lower trace shows the same sample after removal of the unfolded
proteins by gel filtration.
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Figure 3. Amide Region of One-Dimensional
Spectra of the IGF Binding Protein-5
The upper, middle, and lower panels show
the full-length protein of 246 amino acid resi-
dues, a C-terminal fragment of 112 residues,
and an N-terminal fragment of 94 residues,
respectively.
lines for the resonances of larger molecules. Thus, the nice signal dispersion, characteristic of a structured pro-
tein. Again, in this example, the quantitative informationline widths of the signals in any NMR spectrum are
correlated to the size of the molecule. Both these as- on the extent of folding that is available from 1D NMR
can be appreciated. The full-length protein is only aboutpects may be appreciated in Figure 3. The upper panel
shows the spectrum of the 246-residue IGFBP-5 [19] 50%–60% folded. This spectrum (Figure 3, upper panel)
may be seen as a superposition of the two other spectra,that exhibits a rather large peak at the random-coil value
of 8.3 ppm and some signals downfield (that are shifted which show the C-terminal fragment, which is about
30% folded, and the fully folded N-terminal fragmentto higher parts per million values), close to the noise
level. The IGFBP-5 protein comprises conserved N- and (middle and lower panels, respectively; the rest of the
unstructured residues originate from the central domainC-terminal domains of 90 and 112 amino acids, respec-
tively, and a central domain of 40 amino acids. Spectra of IGFBP-5).
Note that the line width of the individual signals hasof the C-and N-terminal fragments of the same protein
(Figure 3, middle and lower panels, respectively) show also improved dramatically in the smaller fragments.
With the line width from known monomeric proteins ofthat there is an unstructured region located in the
C-terminal fragment. The N-terminal fragment shows a given size as a reference, the observation of the line
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Figure 4. The Aliphatic Region of One-
Dimensional Spectra of the Cyclase-Associ-
ated Protein (CAP)
(A) The N-terminal 226-residue construct, as
indicated in the scheme above.
(B) A mixture of several constructs of different
length (residues 1–226, 44–226, 51–226, and
56–226). The overlap leads to broader lines
than in spectrum (A). Short peptides give rise
to sharp signals around 1 ppm.
(C) The stable core of the protein (residues
51–226) only. The sharp signals from impuri-
ties are removed, and the line width is sub-
stantially improved compared with spec-
trum (A).
width in a one-dimensional spectrum will also yield infor- tially folded and a mixture of folded and unfolded pro-
teins is difficult with NMR, without having additionalmation on the molecular weight and aggregation of the
molecule under investigation. Furthermore, attempts to information from, for example, gel filtration or other bio-
chemical methods.prevent aggregation by, for example, dilution of the sam-
ple, addition of mild detergents, such as CHAPS, or One-dimensional spectra may additionally provide in-
formation on -helical or  strand structures in a protein.lowering the pH value can thus be monitored by NMR
to find optimal sample conditions [19–21]. While the The C protons in a helix display few resonances in the
region between 5 and 6 ppm, while those in a  sheetextent of folding is crucial both for X-ray crystallography
and NMR, aggregation is not. Actually, some proteins resonate in this region [24].
The use of one-dimensional spectra to screen for opti-that yield rather poor NMR spectra because of aggrega-
tion or low solubility might give excellent crystals, as mal, fully folded protein fragments may be illustrated by
the example of the cyclase-associated protein (CAP)did p19INK4d [22, 23]. Thus, sample conditions that are
optimal for crystallography might not necessarily be op- [25]. The initial construct of the protein, comprising 226
amino acids, showed considerable line width and wouldtimal for NMR spectroscopy and vice versa. This fact
does not, however, reduce the value of insights given not crystallize (Figure 4A). After the sample was left at
room temperature for 7 days, another one-dimensionalby NMR for crystallography. In order to assess whether
conditions that are optimal for NMR are also optimal spectrum showed, on the one hand, degraded peptide
fragments but, on the other hand, still showed broadfor crystallography, one would have to sample a large
number of proteins. We were informed that such large- lines, not in agreement with the expected shorter protein
fragment (Figure 4B). Mass spectrometry revealed thescale comparisons are under way in the Northeast Struc-
tural Genomics Conosortium in the United States and presence of several protein fragments of different
lengths, ranging from 226 to 173 amino acids. Thus, theat the RIKEN structural genomics project in Japan.
In comparing Figures 2 and 3, we have to point out very sharp peaks around 1 ppm could be attributed
to the cleaved peptide fragments, while the line widththat distinguishing between a protein that is only par-
Ways & Means
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Figure 5. 15N-HSQC Spectra of Unfolded and Folded Proteins
The left panel shows a 15N-HSQC spectrum of a partially unstructured protein fragment of 80 amino acid residues. All signals cluster around
a 1H frequency of 8.3 ppm. Also, the signal dispersion in the 15N dimension is limited. The broad unresolved signals in the middle of the
spectrum indicate either aggregation in the sample or conformational heterogeneity on a ms-s timescale (both cases are unfavorable for
NMR studies). The signal at 10 ppm is not diagnostic for a folded protein but stems from the side chain amide group of a tryptophan residue.
The right panel shows the spectrum of a folded, 55-residue-long construct of the IGFBP-5 protein. The peaks show a large signal dispersion
in both dimensions.
corresponds to the overlap of slightly varying reso- 15N-labeled protein samples are required. The HSQC
shows one peak for every proton bound directly to anances from several fragments of different length. On
the basis of these results, we cloned and expressed, in nitrogen atom and, thus, exactly one signal per residue
in the protein (apart from proline, which is devoid ofE. coli, a new fragment of the protein of 176 residues,
which contained only the unchanged core of the protein. proton-bound nitrogen, and some additional side chain
signals, which can easily be identified, appear).This fragment was not further degraded, even after sev-
eral months. The spectrum of this protein fragment is The positions of the peaks are indicative of structured
or disordered proteins in the same way as describedshown in Figure 4C. Note the absence of the sharp
resonances and the superior line width. NMR has re- above for the one-dimensional spectrum (Figure 5). In
the spectrum of an unfolded protein, all signals clustervealed a stable folded core of the protein, which was
then successfully subjected to the NMR and X-ray struc- in a characteristic “blob” around a 1H frequency of 8.3
ppm, with little signal dispersion in both dimensions. Inture analysis.
The prominent signals from the small peptide frag- the spectrum of a structured protein, the peaks show
large signal dispersion. Thus, if the peaks are assignedments also provide an example for the examination of
a sample’s purity. Any small compounds, be they pep- their respective sequential positions in the polypeptide
chain, disordered regions may be identified.tides or other impurities, will readily show in a one-
dimensional spectrum. As the number of signals in the HSQC spectrum corre-
sponds approximately to the number of residues in the
protein under investigation, conformational heterogene-Two-Dimensional NMR
Because of the greatly improved resolution of two- ity can easily be detected by a surplus of peaks. To
optimize sample conditions, pH titrations or titrationsdimensional experiments, they are frequently used for
screening and binding studies. The simplest and most with cofactors or other molecules as well as variation
of temperature may be performed while repeatedly re-powerful among them is the heteronuclear single-quan-
tum coherence (HSQC) experiment. In an impressive cording HSQC spectra. This is feasible, since the NMR
method is nondestructive and experiments may be re-large-scale approach, Yee et al. [15] have recently inves-
tigated more than 500 proteins from five different organ- peated several times. It has, for example, been shown
by NMR-observed titrations that low temperatures andisms, using 15N-HSQC experiments to screen for those
proteins amenable to NMR structure analysis. This spec- neutral pHs stabilize the folded state of an SH3 domain
of Drosophila drk, while high temperatures and low pHstrum is the first step in any structure elucidation, as it
maps the backbone amide groups of a protein according tend to favor the unfolded state [26]. On the other hand
low pH has also been reported to prevent aggregation,to their proton and nitrogen frequencies. A whole set of
three-dimensional spectra later used to assign the NMR as observed by line width comparison [20].
For full NMR structure investigations, samples of 200–signals to their respective amino acid residues is based
on the HSQC experiment. For this kind of spectrum, 400 l with a protein concentration of 0.5–1.0 mM are
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